ndre is a Fractional CFO with over twenty years of experience in finance and business, including senior roles at Pfizer and biotech company Illumina, a Nasdaq-listed company, as well as working for Private Equity-backed companies. Andre is well-equipped to add significant value to companies across various sectors.

He is a forward-thinking, naturally agile Fractional CFO, adept at positioning companies for sustainable growth, accessing emerging markets, and catalysing revenue expansion while balancing cash flow effectively with efficiency gains. He also has a deep understanding of external influences on decision-making, he drives comprehensive scenario planning, and develops robust risk mitigation strategies.

Andre has vast international experience, particularly in the biotech sector, coupled with strong finance and business acumen, which uniquely positions him to thrive as a Fractional CFO in dynamic and fast-paced environments.

Throughout his career, he has:

• Built and led strong finance teams that played a crucial role in enabling business growth.
• Gained a deep understanding of the requirements of public organisations, particularly IPO readiness and compliance.
• Successfully worked closely with boards, gained expertise in fundraising, and can provide strong references from reputable PE firms.
• Provided financial support for all stages of Research and Development (R&D) initiatives, from pre-revenue to product development.
• Obtained significant expertise in the implementation of effective budget management strategies throughout the entire innovation lifecycle.
• Played a pivotal role in supporting the senior leadership teams, collaborating closely to implement a range of strategic initiatives.
• Successfully navigated the challenges of working across different regions, adapting his leadership style and communication approach to effectively collaborate with teams from various backgrounds.